Knee Cartilage

Cartiheal, a privately held device company developing an innovative cell-free technology for regenerating hyaline cartilage, has raised up to $10 million which it will use to accelerate the development of Agili-CTM, as well as support ongoing clinical studies.

A new concept in non-destructive evaluation of articular cartilage has been CE marked by Biomomentum Inc.

Smith & Nephew is to form a joint venture with Essex Woodlands, a specialist healthcare growth equity and venture capital firm, to create a US-based joint venture with the goal of advancing its Biologics and Clinical Therapy solutions.

Exactech Inc., has announced the initiation of a prospective, randomized, multi-center, clinical trial to evaluate the safety and effectiveness of a new cartilage repair technology.

Rush University Medical Center is testing a new procedure for regenerating damaged articular cartilage in the knee joint to relieve the pain of osteoarthritis.

Kensey Nash Corporation announced that it has submitted an Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to study the use of the Company’s unique biomaterials technology for treating articular cartilage defects of the knee.

BioSyntech, Inc. announced that it has completed enrolment for the Canadian-European pivotal trial of its cartilage repair device, BST-CarGel®.